These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 14992426

  • 1. A pilot study of etanercept in the treatment of primary sclerosing cholangitis.
    Epstein MP, Kaplan MM.
    Dig Dis Sci; 2004 Jan; 49(1):1-4. PubMed ID: 14992426
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of curcumin in primary sclerosing cholangitis: an open label pilot study.
    Eaton JE, Nelson KM, Gossard AA, Carey EJ, Tabibian JH, Lindor KD, LaRusso NF.
    Scand J Gastroenterol; 2019 May; 54(5):633-639. PubMed ID: 31131678
    [Abstract] [Full Text] [Related]

  • 3. A pilot study of pentoxifylline for the treatment of primary sclerosing cholangitis.
    Bharucha AE, Jorgensen R, Lichtman SN, LaRusso NF, Lindor KD.
    Am J Gastroenterol; 2000 Sep; 95(9):2338-42. PubMed ID: 11007239
    [Abstract] [Full Text] [Related]

  • 4. The medical uses and side effects of etanercept with a focus on cutaneous disease.
    Scheinfeld N.
    J Drugs Dermatol; 2004 Sep; 3(6):653-9. PubMed ID: 15624748
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil for the treatment of primary sclerosing cholangitis.
    Talwalkar JA, Angulo P, Keach JC, Petz JL, Jorgensen RA, Lindor KD.
    Am J Gastroenterol; 2005 Feb; 100(2):308-12. PubMed ID: 15667487
    [Abstract] [Full Text] [Related]

  • 6. norUrsodeoxycholic acid improves cholestasis in primary sclerosing cholangitis.
    Fickert P, Hirschfield GM, Denk G, Marschall HU, Altorjay I, Färkkilä M, Schramm C, Spengler U, Chapman R, Bergquist A, Schrumpf E, Nevens F, Trivedi P, Reiter FP, Tornai I, Halilbasic E, Greinwald R, Pröls M, Manns MP, Trauner M, European PSC norUDCA Study Group.
    J Hepatol; 2017 Sep; 67(3):549-558. PubMed ID: 28529147
    [Abstract] [Full Text] [Related]

  • 7. Predictors of successful clinical and laboratory outcomes in patients with primary sclerosing cholangitis undergoing endoscopic retrograde cholangiopancreatography.
    Enns R, Eloubeidi MA, Mergener K, Jowell PS, Branch MS, Baillie J.
    Can J Gastroenterol; 2003 Apr; 17(4):243-8. PubMed ID: 12704468
    [Abstract] [Full Text] [Related]

  • 8. Etanercept in Sjögren's syndrome: a twelve-week randomized, double-blind, placebo-controlled pilot clinical trial.
    Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, Baum BJ, Pillemer SR.
    Arthritis Rheum; 2004 Jul; 50(7):2240-5. PubMed ID: 15248223
    [Abstract] [Full Text] [Related]

  • 9. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
    Tyring S, Gordon KB, Poulin Y, Langley RG, Gottlieb AB, Dunn M, Jahreis A.
    Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
    [Abstract] [Full Text] [Related]

  • 10. The Nonsteroidal Farnesoid X Receptor Agonist Cilofexor (GS-9674) Improves Markers of Cholestasis and Liver Injury in Patients With Primary Sclerosing Cholangitis.
    Trauner M, Gulamhusein A, Hameed B, Caldwell S, Shiffman ML, Landis C, Eksteen B, Agarwal K, Muir A, Rushbrook S, Lu X, Xu J, Chuang JC, Billin AN, Li G, Chung C, Subramanian GM, Myers RP, Bowlus CL, Kowdley KV.
    Hepatology; 2019 Sep; 70(3):788-801. PubMed ID: 30661255
    [Abstract] [Full Text] [Related]

  • 11. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
    Kircik LH.
    J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
    [Abstract] [Full Text] [Related]

  • 12. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis.
    Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, Schroeder DR.
    Chest; 2003 Jul; 124(1):177-85. PubMed ID: 12853521
    [Abstract] [Full Text] [Related]

  • 13. Long-term safety and efficacy of etanercept in patients with psoriasis: an open-label study.
    Leonardi C, Strober B, Gottlieb AB, Elewski BE, Ortonne JP, van de Kerkhof P, Chiou CF, Dunn M, Jahreis A.
    J Drugs Dermatol; 2010 Aug; 9(8):928-37. PubMed ID: 20684143
    [Abstract] [Full Text] [Related]

  • 14. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
    Mease PJ, Kivitz AJ, Burch FX, Siegel EL, Cohen SB, Ory P, Salonen D, Rubenstein J, Sharp JT, Tsuji W.
    Arthritis Rheum; 2004 Jul; 50(7):2264-72. PubMed ID: 15248226
    [Abstract] [Full Text] [Related]

  • 15. A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction.
    Papp KA, Tyring S, Lahfa M, Prinz J, Griffiths CE, Nakanishi AM, Zitnik R, van de Kerkhof PC, Melvin L, Etanercept Psoriasis Study Group.
    Br J Dermatol; 2005 Jun; 152(6):1304-12. PubMed ID: 15948997
    [Abstract] [Full Text] [Related]

  • 16. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
    de Vlam K, Lories RJ.
    Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
    [Abstract] [Full Text] [Related]

  • 17. Once-weekly administration of high-dosage Etanercept in patients with plaque psoriasis: results of a pilot experience (power study).
    Cassano N, Loconsole F, Galluccio A, Miracapillo A, Pezza M, Vena GA.
    Int J Immunopathol Pharmacol; 2006 Mar; 19(1):225-9. PubMed ID: 16569361
    [Abstract] [Full Text] [Related]

  • 18. Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis.
    Mendes FD, Jorgensen R, Keach J, Katzmann JA, Smyrk T, Donlinger J, Chari S, Lindor KD.
    Am J Gastroenterol; 2006 Sep; 101(9):2070-5. PubMed ID: 16879434
    [Abstract] [Full Text] [Related]

  • 19. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
    Strober BE, Clarke S.
    J Drugs Dermatol; 2004 Sep; 3(3):270-2. PubMed ID: 15176161
    [Abstract] [Full Text] [Related]

  • 20. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.
    Moreland LW, Schiff MH, Baumgartner SW, Tindall EA, Fleischmann RM, Bulpitt KJ, Weaver AL, Keystone EC, Furst DE, Mease PJ, Ruderman EM, Horwitz DA, Arkfeld DG, Garrison L, Burge DJ, Blosch CM, Lange ML, McDonnell ND, Weinblatt ME.
    Ann Intern Med; 1999 Mar 16; 130(6):478-86. PubMed ID: 10075615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.